Oleoylcarnitine
|
Basic information |
| Metabolite name | Oleoylcarnitine |
 | HMDB0005065 |
 |
N/A |
 |
46907933 |
| Synonyms | Octadecenoyl-L-carnitine; |
| No. of studies | 8 |
|
Basic information |
| Metabolite name | Oleoylcarnitine |
| HMDB0005065 |
|
N/A |
|
46907933 |
| Synonyms | Octadecenoyl-L-carnitine; |
| No. of studies | 8 |
|
Relationship between Oleoylcarnitine and depression (count: 8) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M039 | Type1 | CRS group vs. control group | Plasma | Wistar rat | Up |
| Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | Serum | ICR mouse | Up |
| Study M103 | Type1 | stress group vs. control group | Plasma | C57BL/6 mouse | Unknown |
| Study M587 | Type2 | MDD group, after 8-week SSRI treatment vs. before treatment | Plasma | Human | Down |
| Study M613 | Type2 | CSDS susceptible + imipramine group vs. CSDS + vehicle group | Nucleus accumbens | C57BL/6 J mouse | Up |
| Study M648 | Type1 | ART-treated HIV with depressive symptom group vs. ART-treated HIV without depressive symptom group, discovery cohort | Plasma | Human | Down |
| Study M870 | Type1 | CRS group vs. control group | Brain | C57BL/6 mouse | Down |
| Study M870 | Type2 | CRS + sertraline group vs. CRS group | Brain | C57BL/6 mouse | Up |
| Study M870 | Type2 | CRS + middle dose of Jia Wei Xiao Yao San group vs. CRS group | Brain | C57BL/6 mouse | Up |
| Study M888 | Type1 | CUMS microbiota group vs. control microbiota group | Serum | C57BL/6J mouse | Up |